2014

Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2013

NEW YORK, Aug. 15, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2013
http://www.reportlinker.com/p0761182/Systemic-Sclerosis-Scleroderma-Global-Clinical-Trials-Review-H1-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2013

Summary

GlobalData's clinical trial report, "Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2013" provides data on the Systemic Sclerosis (Scleroderma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Systemic Sclerosis (Scleroderma). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Systemic Sclerosis (Scleroderma). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Systemic Sclerosis (Scleroderma) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Systemic Sclerosis (Scleroderma) 25
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Actelion Ltd 33
Clinical Trial Overview of Actelion Ltd 33
United Therapeutics Corporation 34
Clinical Trial Overview of United Therapeutics Corporation 34
ISDIN 35
Clinical Trial Overview of ISDIN 35
MediQuest Therapeutics, Inc. 36
Clinical Trial Overview of MediQuest Therapeutics, Inc. 36
MedImmune, LLC 37
Clinical Trial Overview of MedImmune, LLC 37
Celgene Corporation 38
Clinical Trial Overview of Celgene Corporation 38
Benesis Corporation 39
Clinical Trial Overview of Benesis Corporation 39
Actelion Pharmaceuticals Ltd 40
Clinical Trial Overview of Actelion Pharmaceuticals Ltd 40
Daval International Ltd. 41
Clinical Trial Overview of Daval International Ltd. 41
Amira Pharmaceuticals, Inc. 42
Clinical Trial Overview of Amira Pharmaceuticals, Inc. 42
Italfarmaco S.p.A. 43
Clinical Trial Overview of Italfarmaco S.p.A. 43
Apricus Biosciences, Inc. 44
Clinical Trial Overview of Apricus Biosciences, Inc. 44
Active Biotech AB 45
Clinical Trial Overview of Active Biotech AB 45
Pfizer Inc. 46
Clinical Trial Overview of Pfizer Inc. 46
Orion Oyj 47
Clinical Trial Overview of Orion Oyj 47
Sanofi 48
Clinical Trial Overview of Sanofi 48
Novartis AG 49

Clinical Trial Overview of Novartis AG 49
Hoffmann-La Roche Inc. 50
Clinical Trial Overview of Hoffmann-La Roche Inc. 50
Merck & Co., Inc. 51
Clinical Trial Overview of Merck & Co., Inc. 51
Gilead Sciences, Inc. 52
Clinical Trial Overview of Gilead Sciences, Inc. 52
Clinical Trial Overview of Top Institutes / Government 53
Assistance Publique - Hopitaux de Paris 53
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 53
Fred Hutchinson Cancer Research Center 54
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 54
National Institute of Arthritis and Musculoskeletal and Skin Diseases 55
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 55
Duke University 56
Clinical Trial Overview of Duke University 56
Hospital for Special Surgery 57
Clinical Trial Overview of Hospital for Special Surgery 57
Georgetown University 58
Clinical Trial Overview of Georgetown University 58
University of Michigan 59
Clinical Trial Overview of University of Michigan 59
Stanford University 60
Clinical Trial Overview of Stanford University 60
National Center for Research Resources 61
Clinical Trial Overview of National Center for Research Resources 61
Boston University 62
Clinical Trial Overview of Boston University 62
Rouen University Hospital 63
Clinical Trial Overview of Rouen University Hospital 63
University of California, Los Angeles 64
Clinical Trial Overview of University of California, Los Angeles 64

Northwestern University 65
Clinical Trial Overview of Northwestern University 65
The Medical University of Graz 66
Clinical Trial Overview of The Medical University of Graz 66
The National Institute of Allergy and Infectious Diseases 67
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 67
Charite - Universitatsmedizin Berlin 68
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 68
Sanjay Gandhi Postgraduate Institute of Medical Sciences 69
Clinical Trial Overview of Sanjay Gandhi Postgraduate Institute of Medical Sciences 69
Arthritis Research UK 70
Clinical Trial Overview of Arthritis Research UK 70
The University of Florence 71
Clinical Trial Overview of The University of Florence 71
Federal University of Sao Paulo 72
Clinical Trial Overview of Federal University of Sao Paulo 72
Five Key Clinical Profiles 73
Appendix 111
Abbreviations 111
Definitions 111
Research Methodology 112
Secondary Research 112
About GlobalData 113
Contact Us 113
Disclaimer 113
Source 114

List of Tables

Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Zone, 2013* 9
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 12
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 13
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, North America, Top Countries, 2013* 14
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 15
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 16
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, BRIC Countries, 2013* 17
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, G7 Countries, 2013* 18
Systemic Sclerosis (Scleroderma) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, E7 Countries, 2013* 20
Systemic Sclerosis (Scleroderma) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Phase, 2013* 22
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 23
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31

Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2013* 33
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2013* 34
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by ISDIN, 2013* 35
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by MediQuest Therapeutics, Inc., 2013* 36
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2013* 37
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2013* 38
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Benesis Corporation, 2013* 39
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Pharmaceuticals Ltd, 2013* 40
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daval International Ltd., 2013* 41
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amira Pharmaceuticals, Inc., 2013* 42
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Italfarmaco S.p.A., 2013* 43
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Apricus Biosciences, Inc., 2013* 44
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Active Biotech AB, 2013* 45

Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 46
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Orion Oyj, 2013* 47
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 48
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 49
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoffmann-La Roche Inc., 2013* 50
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 51
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2013* 52
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 53
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2013* 54
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2013* 55
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 56
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital for Special Surgery, 2013* 57
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgetown University, 2013* 58
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2013* 59
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2013* 60
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2013* 61
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2013* 62
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2013* 63
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2013* 64
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2013* 65
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2013* 66
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 67
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2013* 68
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanjay Gandhi Postgraduate Institute of Medical Sciences, 2013* 69
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Arthritis Research UK, 2013* 70
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Florence, 2013* 71
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2013* 72

List of Figures

Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 9
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 12
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 13
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 14
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 15
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 16
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, BRIC Countries (%), 2013* 17
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, G7 Countries (%), 2013* 18
Systemic Sclerosis (Scleroderma) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, E7 Countries (%), 2013* 20
Systemic Sclerosis (Scleroderma) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 22

Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 23
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
GlobalData Methodology 112

To order this report:
Pathology Industry:
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2013


Contact Clare: clare@reportlinker.com  
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.